FMP
FSD Pharma Inc.
HUGE
NASDAQ
Inactive Equity
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.
0.0899 USD
-0.0101 (-11.23%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Zeeshan Saeed
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.fsdpharma.comexchange
NASDAQ
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.
CIK
0001771885
ISIN
CA35954B4047
CUSIP
35954B206
Address
199 Bay Street
Phone
416 854 8884
Country
CA
Employee
17
IPO Date
Jun 8, 2018
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
HUGE Financial Summary
CIK
0001771885
Exchange
NASDAQ
Industry
Drug Manufacturers -...
Sector
Healthcare
CUSIP
35954B206
ISIN
CA35954B4047
Country
CA
Price
0.09
Beta
0.85
Volume Avg.
196.16k
Market Cap
66.67k
Shares
-
52-Week
0.087-109.1935
DCF
0.04
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.01
P/B
-
Website
https://www.fsdpharma.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest HUGE News
It looks like there's no news available.
